FR&D leaders congregate to highlight the huge potential of drug development and delivery systems to create IP, improve product life-cycle management, gain cost and market differentiation and become major determinants of success
KEY NOTE ADDRESS: Molecule to market
Intraspheres TA as functional starter core for ER Formulations
Height resolution nano and micron particle characterisation – Pharma development to production
QbD: Lessons learned, challenges and opportunities
Panel discussion: Futuristic formulation development and drug delivery technologies